Robert Bohinski

Robert Bohinski, LPEC has extensive work experience in the field of audit and quality management in the pharmaceutical industry. Robert has held various roles in reputable companies such as Morphic Therapeutic, GlaxoSmithKline, and Malaria Consortium.

At Morphic Therapeutic, Robert currently serves as the Associate Director Quality - Audit and Vendor Management. In this remote position, they are responsible for overseeing global audit management and vendor support for development and clinical study activities.

Prior to their role at Morphic Therapeutic, Robert worked for GlaxoSmithKline for over a decade, holding the position of Manager - Audit and Assurance until their retirement. During their tenure, they provided leadership in auditing research practices, including GCP and GLP, and pharmacovigilance areas across various divisions of the company. Robert also played a crucial role in risk management and control expertise.

Before joining GlaxoSmithKline, Robert served as an Audit Manager on a pro bono basis with the NGO Malaria Consortium. This international assignment involved conducting Finance and Procurement audits in Mozambique and Nigeria, identifying compliance issues, and recommending corrective actions to enhance controls and mitigate the impact of future donor funding disallowance.

In the early years of their career, Robert worked at GSK as a Regulatory Affairs Manager/Associate Director, representing regulatory departments in global project meetings and providing guidance on regulatory guidelines for clinical research programs. Robert also managed complex regulatory submissions in a matrix environment. Additionally, Robert held a role as an Analytical Chemist - New Product Development during this time.

Overall, Robert Bohinski's work experience demonstrates their expertise in audit management, quality assurance, and regulatory affairs in the pharmaceutical industry.

Robert Bohinski, LPEC received their Bachelor of Science degree in Chemistry (with a focus in Analytical Sciences) from the University of the Sciences in Philadelphia, where they attended from 1984 to 1988. Prior to that, they attended Bishop Hoban, but no specific degree information is provided. In addition to their academic background, Robert has also obtained several certifications, including GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus), Good Laboratory Practice (GLP), GDPR for Research and Higher Ed, and Leadership Professional in Ethics & Compliance Certification from the CITI Program and Ethics & Compliance Initiative (ECI) respectively.